Background
==========

Breast milk is recognized as a predominant mode of HIV-1 infection in infants. Cell-associated HIV-1 may be the main source of virus transmission during early phases of breast-feeding. We have previously observed that HIV-1-infected cells spontaneously producing virus persist in breast-milk from women under antiretroviral therapy. Treatment of expressed milk with a microbicide such as Sodium dodecyl sulfate (SDS) is proposed as a simple and safe option to inactivate both cell free and cell associated HIV-1 when formula feeding is not practicable. However, the effect of SDS on spontaneously HIV-1-producing CD4^+^T cells in breast milk has not been fully explored.

Materials and methods
=====================

In this report human milk was spiked by HIV-1-infected cells and treated with increasing exposure time and SDS concentration. CD4^+^T cell apoptosis and death, cell-associated HIV-1 RNA production, and spontaneous HIV-1-Ag cell secretion were quantified after SDS treatment.

Results
=======

Cell death increases in presence of SDS in a concentration- and time-dependent manner, 50% of T lymphocytes death after 2 minutes with 0.14% SDS and 90% after 10 minutes with 0.1% SDS (Fig. [1A](#F1){ref-type="fig"}). Undetectable HIV-1 RNA cell production was achieved following exposure with a minimum concentration of 0.1% SDS during 2 minutes, IC50 = 0.03% (Fig. [1B](#F1){ref-type="fig"}). The inhibition of HIV-1 Ag secretion was explored at a single cell level by ELISpot assay. Using this method inactivation was 100% for SDS concentrations ≥0.25% within 2 min (Fig. [1C](#F1){ref-type="fig"}).
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Conclusion
==========

By comparison with results previously reported using an infectivity model based on β-galactosidase MAGI cells^1^, we observed that a two fold higher SDS concentration was required to complete inactivation of HIV-1-Ag-secreting cells. This concentration remains in the reported safe limits for ingestion of SDS by children (1 g/kg/day). Regarding the possible occurrence of transmission to the infant after controlling cell-free virus in breast milk from women on antiretroviral therapy, SDS treatment of expressed breast milk may be an interesting strategy to optimized the prevention of HIV-1 pediatric transmission.
